Global Heart Transplant Market was valued at USD XX Billion in the year 2021. Global Heart Transplant Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Heart Transplant Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Ventricular Assist Devices, Total Artificial Hearts, and Others. In which Ventricular Assist Devices for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as SynCardia Systems, LLC, HeartWare International, Inc., Apaxis Medical, Inc., Calon Cardio, Optum, Inc., Thoratec Corporation, CardiacAssist, Inc., and CARMAT SA.
Particular |
Scope |
Region |
- North America: United States, Canada, and Mexico.
- South & Central America: Argentina, Chile, and Brazil.
- Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
- Europe: UK, France, Italy, Germany, Spain, and Russia.
- Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, Australia and Southeast Asia.
|
Historic Year |
2016-2020 |
Base Year |
2021 |
Forecast Year |
2022 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Component, technology, type, application, region |
This research report will answer the following questions:
- Which are the major players and what are their business plans on a global scale?
- Which are the major industry regions?
- Growth opportunities and trend analysis?
- Competition strategy and market share analysis?
1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 HEART TRANSPLANT TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 VENTRICULAR ASSIST DEVICES
5.6 TOTAL ARTIFICIAL HEARTS/HEART-LUNG MACHINE
5.7 OTHERS
6 HEART TRANSPLANT PATIENT’S AGE ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET PATIENT’S AGE ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 LESS THAN 60
6.6 GREATER THAN 60
7 HEART TRANSPLANT MARKET APPLICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 HOSPITALS
7.6 CARDIAC INSTITUTES
7.7 OTHERS
8 GLOBAL HEART TRANSPLANT REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.2.3 Y-O-Y GROWTH TREND ANALYSIS
8.2.3.1 U.S.
8.2.3.2 Canada
8.2.3.3 Mexico
8.3 ASIA-PACIFIC
8.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.3.2 Y-O-Y GROWTH TREND ANALYSIS
8.3.2.1 China
8.3.2.2 Japan
8.3.2.3 Korea
8.3.2.4 India
8.3.2.5 Southeast Asia
8.4 MIDDLE EAST AND AFRICA
8.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4.3 Y-O-Y GROWTH TREND ANALYSIS
8.4.3.1 Saudi Arabia
8.4.3.2 UAE
8.4.3.3 Egypt
8.4.3.4 Nigeria
8.4.3.5 South Africa
8.5 EUROPE
8.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.5.3 Y-O-Y GROWTH TREND ANALYSIS
8.5.3.1 Germany
8.5.3.2 France
8.5.3.3 UK
8.5.3.4 Russia
8.5.3.5 Italy
8.6 LATIN AMERICA
8.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.6.3 Y-O-Y GROWTH TREND ANALYSIS
8.6.3.1 Brazil
8.6.3.2 Argentina
8.6.3.3 Columbia
9 MARKET PLAYERS
9.1 SYNCARDIA SYSTEMS, LLC
9.1.1 BUSINESS OVERVIEW:
9.1.2 PRODUCT PORTFOLIO
9.1.3 RECENT DEVELOPMENTS
9.1.4 SWOT ANALYSIS:
9.2 HEARTWARE INTERNATIONAL, INC.
9.3 APAXIS MEDICAL, INC.
9.4 CALON CARDIO
9.5 OPTUM, INC.
9.6 THORATEC CORPORATION
9.7 CARDIACASSIST, INC.
9.8 CARMAT SA
9.9 TRANSMEDICS, INC.
9.10 MEDTRONIC PLC.
9.11 ABBOTT LABORATORIES
9.12 ABIOMED
9.13 BERLIN HEART
9.14 BIVACOR INC.
9.15 CAREDX, INC
9.16 CORWAVE S.A.
10 ABOUT US
TABLE 1 HEART TRANSPLANT REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL HEART TRANSPLANT MARKET, 2021–2030, (USD MILLION)
TABLE 3 HEART TRANSPLANT CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL HEART TRANSPLANT HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL HEART TRANSPLANT HISTORICAL MARKET PATIENT’S AGE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL HEART TRANSPLANT HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 NORTH AMERICA HEART TRANSPLANT HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 NORTH AMERICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 NORTH AMERICA HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 13 NORTH AMERICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 U.S. HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 15 U.S. HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 16 U.S. HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 17 CANADA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 18 CANADA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 19 MEXICO HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 20 MEXICO HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 21 APAC HEART TRANSPLANT HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 22 ASIA-PACIFIC HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 23 ASIA-PACIFIC HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 25 CHINA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 CHINA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 JAPAN HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 28 JAPAN HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 29 KOREA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 30 KOREA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 31 INDIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 32 INDIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 33 SOUTHEAST ASIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 SOUTHEAST ASIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA HEART TRANSPLANT HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 39 SAUDI ARABIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 SAUDI ARABIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 UAE HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 UAE HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 EGYPT HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 44 EGYPT HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 45 NIGERIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 46 NIGERIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 47 SOUTH AFRICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 48 SOUTH AFRICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 49 EUROPE HEART TRANSPLANT HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 50 EUROPE HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 51 EUROPE HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 52 EUROPE HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 53 GERMANY HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 GERMANY HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 FRANCE HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 FRANCE HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 UK HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 UK HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 RUSSIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 60 RUSSIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 61 ITALY HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 62 ITALY HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 63 LATIN AMERICA HEART TRANSPLANT HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 64 LATIN AMERICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 LATIN AMERICA HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 66 LATIN AMERICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 67 BRAZIL HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 BRAZIL HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 ARGENTINA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 ARGENTINA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 COLUMBIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 COLUMBIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL HEART TRANSPLANT MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL HEART TRANSPLANT CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL HEART TRANSPLANT CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 HEART TRANSPLANT TYPE ANALYSIS
FIGURE 11 GLOBAL HEART TRANSPLANT CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 HEART TRANSPLANT PATIENT’S AGE ANALYSIS
FIGURE 13 GLOBAL HEART TRANSPLANT CURRENT AND FUTURE MARKET PATIENT’S AGE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 HEART TRANSPLANT APPLICATION ANALYSIS
FIGURE 15 GLOBAL HEART TRANSPLANT CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 GLOBAL HEART TRANSPLANT CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 17 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MARKET SHARE BY COUNTRY
FIGURE 19 NORTH AMERICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 NORTH AMERICA HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 NORTH AMERICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 U.S. HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 U.S. HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 CANADA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 CANADA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 MEXICO HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 MEXICO HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 MARKET SHARE BY COUNTRY
FIGURE 29 APAC HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 APAC HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 APAC HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 CHINA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 CHINA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 JAPAN HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 JAPAN HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 KOREA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 KOREA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 INDIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 INDIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 SOUTHEAST ASIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 SOUTHEAST ASIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 MARKET SHARE BY COUNTRY
FIGURE 43 MIDDLE EAST AND AFRICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 MIDDLE EAST AND AFRICA HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 MIDDLE EAST AND AFRICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 SAUDI ARABIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 SAUDI ARABIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 UAE HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 UAE HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 EGYPT HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 EGYPT HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 NIGERIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 NIGERIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 SOUTH AFRICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 SOUTH AFRICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 MARKET SHARE BY COUNTRY
FIGURE 57 EUROPE HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 EUROPE HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 EUROPE HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 GERMANY HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 GERMANY HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 FRANCE HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 FRANCE HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 UK HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 UK HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 RUSSIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 RUSSIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 ITALY HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 ITALY HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 LATIN AMERICA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 LATIN AMERICA HEART TRANSPLANT CURRENT AND FUTURE PATIENT’S AGE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 LATIN AMERICA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 BRAZIL HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 BRAZIL HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 ARGENTINA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 ARGENTINA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 COLUMBIA HEART TRANSPLANT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 COLUMBIA HEART TRANSPLANT CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 FINANCIAL OVERVIEW: